Complétez C1q, en vrac humaine

Code: 204876-10mg D2-231

Non disponible en dehors du Royaume-Uni et de l'Irlande

Biochem/physiol Actions

≥150,000 C1qH50 units/mg and ≥70% C1q activity in normal human serum on a mg/mg basis

General description

Nat...


en savoir plus

Votre prix
£6,820.00 EACH

Non disponible en dehors du Royaume-Uni et de l'Irlande

Biochem/physiol Actions

≥150,000 C1qH50 units/mg and ≥70% C1q activity in normal human serum on a mg/mg basis

General description

Native, human C1q complement component. Glycoprotein composed of 18 polypeptide chains consisting of three nonidentical subunits A, B, and C, of M.W. 29,000, 26,000 and 19,000, respectively. Present in normal human serum at 70 µg/ml. Found in circulating blood plasma complexed with two C1r and two C1s molecules to form the first component of complement (C1). Activation of complement via classical pathway is triggered by binding of C1q to immune complexes containing IgG or IgM or to a variety of other activating substances, including C-reactive protein, retroviruses, and mitochondria. Subsequent to C1q binding, C1r and C1s are converted to proteolytic enzymes that are responsible for continuation of activation via the classical pathway.

Native, human C1q complement component. Glycoprotein composed of 18 polypeptide chains consisting of three nonidentical subunits, A, B, and C, of M.W. 29 kDa, 26 kDa, and 19 kDa, respectively. Present in normal human serum at 70 µg/ml. Found in circulating blood plasma complexed with two C1r and two C1s molecules to form the first component of complement (C1). Activation of complement via classical pathway is triggered by binding of C1q to immune complexes containing IgG or IgM or to a variety of other activating substances, including C-reactive protein, retroviruses, and mitochondria. Subsequent to C1q binding, C1r and C1s are converted to proteolytic enzymes that are responsible for continuation of activation via the classical pathway.

Legal Information

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

Other Notes

Loos, M., et al. 1980. J. Immunol. 124, 59.Kolb, W.P., et al. 1979. J. Immunol. 122, 2103.

Packaging

1 mg in Plastic ampoule

Please refer to vial label for lot-specific concentration.

Physical form

In 300 mM NaCl, 10 mM HEPES, 40% glycerol, pH 7.2.

Preparation Note

Prepared from serum that has been shown by certified tests to be negative for HBsAg and for antibodies to HIV and HCV.

Reconstitution

Following initial thaw, aliquot and freeze (-70°C).

Warning

Toxicity: Standard Handling (A)

assay≥90% (SDS-PAGE)
formliquid
impuritiesIgG, IgA, IgM, C3, C4, albumin, fibrinogen, α?-macroglobulin, trace
manufacturer/tradenameCalbiochem®
Quality Level200
shipped inwet ice
storage conditionavoid repeated freeze/thaw cycles, OK to freeze
storage temp.−70°C
Code
Description
Unité de vente
Prix annoncé
Qté
204876-1MG
Unité:1MG
Prix annoncé: £421.00
Source:Prix annoncé
204876-1UNMG
Unité:EACH
Prix annoncé: £5,610.00
Source:Prix annoncé
Abandonné
Ce produit répond aux critères suivants: